BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 21, 2019
View Archived Issues
Malaria vaccine has indirect protective effects
Read More
ActoBio Therapeutics announces IND approval for AG-017 for the treatment of celiac disease
Read More
Oral HRI activator EPB-53 improves glucose intolerance through FGF21
Read More
Experiments reveal the role of GDNF in intestinal epithelial barrier dysfunction in IBD
Read More
Study of RAC1 P29S mutation in melanoma points to target for reversing BRAF inhibitor resistance
Read More
Aerie initiates first-in-human study of AR-13503 sustained-release intravitreal Implant
Read More
First patient dosed in global phase II study of BT-11 in mild to moderate ulcerative colitis
Read More
Synlogic discontinues development of SYNB-1020 for the treatment of hyperammonemia
Read More
PI3K-alpha tested as a therapeutic target for prevention of heterotopic ossification
Read More
Novel mannosylated nanovaccines sensitize melanoma to immune checkpoint modulators
Read More
The other end of APP
Read More
Vertex Pharmaceuticals, Merck Patent disclose eIF-2-alpha kinase GCN2 inhibitors
Read More
More evidence links Schwann cells to pain
Read More
Sinovent discovers beta-lactamase inhibitors
Read More
Tau imagining agents patented by AC Immune, Life Molecular Imaging
Read More
Blastocyst-like embryonic structure grown from stem cells
Read More
ST Pharm presents new antivirals
Read More
New cyclin-dependent kinase 4/6 inhibitors identified at Beta Pharma
Read More
Phase III NEPTUNE study does not meet primary endpoint in patients with high TMB
Read More
Mersana Therapeutics initiates expansion portion of phase I trial of XMT-1536
Read More
First patient enrolled in observational study of children and adolescents with Dravet syndrome
Read More